Sanyuan Biotechnology: Announcement on the Election of Employee Representative Directors
Securities code: 301206 Securities abbreviation: Sanyuan Biotechnology Announcement number: 2025-077
Shandong Sanyuan Biotechnology Co., Ltd.
Announcement on the Election of Employee Representative Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
In order to further improve the corporate governance structure, in accordance with the "Company Law", "Guidelines on the Articles of Association of Listed Companies", "Shenzhen Stock Exchange GEM Stock Listing Rules", "Shenzhen Stock Exchange Listed Companies Self-Regulatory Guidelines No. 2 - Standardized Operation of GEM Listed Companies" and other laws and regulations, normative documents and the relevant provisions of the "Articles of Association", Shandong Sanyuan Biotechnology Co., Ltd. (hereinafter referred to as the "Company") held the 2025 Meeting on September 15, 2025. At the first employee representative conference in 2025, after deliberation and democratic election by the employee representatives present, it was unanimously agreed that Mr. Zheng Haijun would serve as the employee representative director of the company’s fifth board of directors (see the attachment for resume details). His term will be from the date of review and approval by the first employee representative conference in 2025 to the expiration date of the fifth board of directors.
Mr. Zheng Haijun was originally a non-employee representative director of the company's fifth board of directors. After being changed to an employee representative director of the fifth board of directors, the composition of the company's fifth board of directors remains unchanged.
After the election is completed, the total number of directors who concurrently hold senior management positions and employee representatives on the company's board of directors does not exceed one-half of the company's total directors, which is in compliance with relevant laws, regulations and the Articles of Association.
Announcement hereby
Board of Directors of Shandong Sanyuan Biotechnology Co., Ltd.
Attachment September 15, 2025
Resume of employee representative director of the fifth session of the company's board of directors
Zheng Haijun, male, Han nationality, born in November 1980, Chinese nationality, no permanent residence abroad, majoring in electrification of industrial enterprises, college degree, senior engineer. From July 1998 to February 2002, he worked at Binzhou Warp Knitting Factory in Shandong Province as a production workshop clerk; from February 2002 to September 2015, he worked at Huafang Co., Ltd. as a technician in the electrical equipment department; from September 2015 to present, he worked at Shandong Sanyuan Biotechnology Co., Ltd. as assistant to the general manager; from July 2018 to present, he worked at Shandong Sanyuan Biotechnology Co., Ltd. as a director.
As of the date of the announcement, Mr. Zheng Haijun holds 120,000 shares of the company; there is no related relationship with the company’s controlling shareholders, actual controllers, shareholders holding more than 5% of the shares, directors and senior managers of the company; there is no "Company Law" or "Self-discipline Supervision Guidelines for Listed Companies of the Shenzhen Stock Exchange" No. 2 No. - Standardized Operation of Listed Companies on the Growth Enterprise Market" and other laws and regulations and other provisions are not applicable to serving as directors and senior managers; there is no market ban measure taken by the China Securities Regulatory Commission to prohibit serving as directors or senior managers of listed companies, and the period has not yet expired; there is no situation that has been publicly determined by the stock exchange to be unsuitable to serve as directors or senior managers of listed companies, and the period has not yet expired situation; has not been subject to administrative punishment by the China Securities Regulatory Commission in the past thirty-six months; has not been publicly condemned by the stock exchange or criticized three times or more in the past thirty-six months; has not been investigated by judicial authorities for suspected crimes or investigated by the China Securities Regulatory Commission for suspected violations of laws and regulations without clear conclusions; has no bad records such as major breach of trust; and its qualifications are in compliance with the "Company Law" "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operations of GEM Listed Companies" and other laws and regulations, normative documents and the "Articles of Association".